Login / Signup

Transcription factor Sp9 is a negative regulator of D1-type MSN development.

Zhenmeiyu LiZicong ShangMengge SunXin JiangYu TianLin YangZiwu WangZihao SuGuoping LiuXiaosu LiYan YouZhengang YangZhejun XuZhuangzhi Zhang
Published in: Cell death discovery (2022)
The striatum is the main input structure of the basal ganglia, receiving information from the cortex and the thalamus and consisting of D1- and D2- medium spiny neurons (MSNs). D1-MSNs and D2-MSNs are essential for motor control and cognitive behaviors and have implications in Parkinson's Disease. In the present study, we demonstrated that Sp9-positive progenitors produced both D1-MSNs and D2-MSNs and that Sp9 expression was rapidly downregulated in postmitotic D1-MSNs. Furthermore, we found that sustained Sp9 expression in lateral ganglionic eminence (LGE) progenitor cells and their descendants led to promoting D2-MSN identity and repressing D1-MSN identity during striatal development. As a result, sustained Sp9 expression resulted in an imbalance between D1-MSNs and D2-MSNs in the mouse striatum. In addition, the fate-changed D2-like MSNs survived normally in adulthood. Taken together, our findings supported that Sp9 was sufficient to promote D2-MSN identity and repress D1-MSN identity, and Sp9 was a negative regulator of D1-MSN fate.
Keyphrases
  • transcription factor
  • poor prognosis
  • functional connectivity
  • spinal cord
  • long non coding rna
  • minimally invasive
  • spinal cord injury
  • social media
  • parkinson disease
  • health information